Xilei san ameliorates experimental colitis in rats by selectively degrading proinflammatory mediators and promoting mucosal repair
- PMID: 25120575
- PMCID: PMC4120479
- DOI: 10.1155/2014/569587
Xilei san ameliorates experimental colitis in rats by selectively degrading proinflammatory mediators and promoting mucosal repair
Abstract
Xilei san (XLS), a herbal preparation widely used in China for erosive and ulcerative diseases, has been shown to be effective in ulcerative colitis (UC). The present experiments were conducted to assess its efficacy and determine its mechanism of action in a rat model that resembles human UC. The model was induced by adding 4% dextran sulfate sodium (DSS) to the rats' drinking water for 7 days. XLS was administered daily by retention enema from day 2 to day 7; the rats were sacrificed on day 8. The colon tissues were obtained for further experiments. A histological damage score and the activity of tissue myeloperoxidase were used to evaluate the severity of the colitis. The colonic cytokine levels were detected in a suspension array, and epithelial proliferation was assessed using Ki-67 immunohistochemistry. Intrarectal administration of XLS attenuated the DSS-induced colitis, as evidenced by a reduction in both the histological damage score and myeloperoxidase activity. It also decreased the levels of proinflammatory cytokines, but increased the mucosal repair-related cytokines. In addition, the epithelial Ki-67 expression was upregulated by XLS. These results suggest that XLS attenuates DSS-induced colitis by degrading proinflammatory mediators and promoting mucosal repair. XLS could be a potential topical treatment for human UC.
Figures
Similar articles
-
Intracolonically administered adeno-associated virus-bone morphogenetic protein-7 ameliorates dextran sulphate sodium-induced acute colitis in rats.J Gene Med. 2012 Jul;14(7):482-90. doi: 10.1002/jgm.2642. J Gene Med. 2012. PMID: 22700475
-
Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.Pharmacol Res. 2016 Aug;110:227-239. doi: 10.1016/j.phrs.2016.02.010. Epub 2016 Mar 9. Pharmacol Res. 2016. PMID: 26969793
-
Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis.PLoS One. 2009 Jun 29;4(6):e6073. doi: 10.1371/journal.pone.0006073. PLoS One. 2009. PMID: 19562033 Free PMC article.
-
Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice.J Ethnopharmacol. 2017 Feb 23;198:389-398. doi: 10.1016/j.jep.2017.01.042. Epub 2017 Jan 22. J Ethnopharmacol. 2017. PMID: 28119098
-
Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis.World J Gastroenterol. 2018 Apr 28;24(16):1766-1778. doi: 10.3748/wjg.v24.i16.1766. World J Gastroenterol. 2018. PMID: 29713130 Free PMC article.
Cited by
-
Effects of indigo naturalis on colonic mucosal injuries and inflammation in rats with dextran sodium sulphate-induced ulcerative colitis.Exp Ther Med. 2017 Aug;14(2):1327-1336. doi: 10.3892/etm.2017.4701. Epub 2017 Jun 28. Exp Ther Med. 2017. PMID: 28781623 Free PMC article.
-
Effect of huankuile on colon injury in rats with ulcerative colitis by reducing TNF-α and MMP9.Eur J Med Res. 2024 Feb 6;29(1):102. doi: 10.1186/s40001-024-01695-w. Eur J Med Res. 2024. PMID: 38321559 Free PMC article.
-
Implication of Nrf2/HO-1 pathway in the coloprotective effect of coenzyme Q10 against experimentally induced ulcerative colitis.Inflammopharmacology. 2017 Feb;25(1):119-135. doi: 10.1007/s10787-016-0305-0. Epub 2017 Jan 3. Inflammopharmacology. 2017. PMID: 28050757
-
Pain matrix shift in the rat brain following persistent colonic inflammation revealed by voxel-based statistical analysis.Mol Pain. 2019 Jan-Dec;15:1744806919891327. doi: 10.1177/1744806919891327. Mol Pain. 2019. PMID: 31709891 Free PMC article.
-
Favorable results from the use of herbal and plant products in inflammatory bowel disease: evidence from experimental animal studies.Ann Gastroenterol. 2016 Jul-Sep;29(3):268-81. doi: 10.20524/aog.2016.0059. Epub 2016 Feb 20. Ann Gastroenterol. 2016. PMID: 27366027 Free PMC article. Review.
References
-
- Kornbluth A, Sachar DB. Gastroenterology PPCotACo. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. The American Journal of Gastroenterology. 2010;105(3):501–524. - PubMed
-
- Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60(5):571–607. - PubMed
-
- Travis SP, Stange EF, Lemann M, et al. European evidence-based Consensus on the management of ulcerative colitis: current management. Journal of Crohn's and Colitis. 2008;2(1):24–62. - PubMed
-
- Fukunaga K, Ohda Y, Hida N, et al. Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitis. Journal of Gastroenterology Hepatology. 2012;27(12):1808–1815. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials